Selank : Tuftsin-Derived Heptapeptide and Neuromodulatory Research Pathways
Introduction Selank is a synthetic heptapeptide derived from the endogenous immunomodulatory peptide Tuftsin. Its sequence, ThrLysProArgProGlyPro, was engineered for enhanced stability, resistance to enzymatic degradation, and improved neuromodulatory properties. Research explores Selank’s potential influence on neurotransmitter regulation, stressresponse signaling, BDNFassociated pathways, immune–neural communication, and cognitive processing networks. Structural Biology of Selank Selank is structurally based on the ThrLysProArg motif of Tuftsin, extended with ProGlyPro to enhance conformational stability and metabolic resistance. The additional residues increase peptide rigidity, improve receptor interactions in research models, and reduce susceptibility to peptidases. Mechanistic Pathways in Neuromodulatory Research Selank is studied for its influence on neurotransmitter and neuroimmune systems. Research indicates potential modulation of GABA turnover, GABA synthesis enzymes, and GABAA receptorassociated functions. Additional findings examine Selank’s relationships with serotonergic and catecholaminergic signaling, including serotonin synthesis, dopamine turnover, and norepinephrinerelated stress pathways. BDNFAssociated Pathways Research models show Selank may influence brainderived neurotrophic factor (BDNF) expression and associated transcriptional networks. BDNF is involved in synaptic plasticity, neuronal survival, dendritic branching, and learning mechanisms. Selank also appears in studies exploring TrkB receptorassociated pathways that govern longterm potentiation and neural adaptation. Neuroimmune Modulation Due to its Tuftsin origin, Selank retains relevance in immunerelated pathways. Studies evaluate its effects on cytokine expression patterns, including IL6, TNFα, and interferonlinked signaling. Additional models explore microglial activity, including inflammatory gene expression, neuroimmune communication, and synapticenvironment regulation. StressResponse and HPAAxis Research Selank is examined in research involving corticotropinreleasing factor (CRF), hypothalamic–pituitary–adrenal (HPA) axis signaling, and stresspeptide pathways. These models explore the compound’s potential influence on adaptive and maladaptive stressresponse systems. Synaptic Plasticity and Cognitive Pathways Studies on hippocampal gene expression suggest Selank’s involvement in regulating synaptic proteins, kinase pathways, neurotransmitter receptor expression, and immediateearly genes such as cFos and Arc. Research also explores Selank’s potential effects on neural oscillations, theta–gamma coupling, and excitatory–inhibitory balance. Metabolic and Monoamine Regulation Research involving Selank includes examination of monoamine oxidase (MAO) activity, COMT metabolic pathways, glutamate/GABA homeostasis, and tryptophan–kynurenine balance. These pathways highlight the compound’s broad neurometabolic relevance. Summary Selank is a Tuftsinderived heptapeptide studied for its neuromodulatory and neuroimmune regulatory properties. Research highlights its involvement in neurotransmitter systems, BDNFassociated pathways, stressresponse regulation, microglial activity, synaptic plasticity, and monoamine metabolism. Its structural stability and dual neuroimmune positioning make Selank a valuable tool in advanced neurobiological research. Educational & Research Disclaimer This article is for educational and scientific research purposes only. No therapeutic claims or usage recommendations are provided. Compounds referenced are not approved for human use and are intended solely for controlled laboratory experimentation. FAQ: What is Selank? Selank is a synthetic heptapeptide derived from the endogenous immunomodulatory peptide tuftsin. It has been studied in experimental models for its role in neuromodulatory signaling and immune–neural communication. How is Selank classified in research literature? In the scientific literature, Selank is classified as a neuromodulatory peptide and is primarily investigated in preclinical and mechanistic research models rather than clinical therapeutic contexts. What biological pathways are studied with Selank? Research involving Selank has examined pathways related to neurotransmitter regulation, stressresponse signaling, immune–neural interactions, and BDNFassociated neuromodulatory networks. Is Selank intended for human or clinical use? No. Selank is supplied strictly for laboratory and research use. It is not approved for human consumption, medical treatment, or clinical application. PMID: PMID: 10470086 – Experimental studies describing the anxiolyticlike and neuromodulatory properties of Selank in animal models. PMID: 16127768 – Research examining Selank’s influence on neurochemical signaling and stressrelated pathways in preclinical systems. PMID: 12617360 – Analysis of tuftsinderived peptides, including Selank, and their immunomodulatory and neuroimmune interactions.
For research use only. Not for human consumption.